Several Drugs Containing Valsartan Being Recalled Due to Contamination With a Potential Carcinogen
Published July 10, 2018, 1:23 p.m.
Several drugs containing the ingredient valsartan are being recalled by their manufacturers. An impurity, N-nitrosodimethylamine (NDMA), was found in the valsartan used in these products. NDMA is a potential human carcinogen, which means that it could cause cancer with long-term exposure. Learn more by visiting the Health Canada advisory.